8,505 Shares in MetLife, Inc. $MET Bought by Fideuram Asset Management Ireland dac

Fideuram Asset Management Ireland dac bought a new position in MetLife, Inc. (NYSE:MET) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 8,505 shares of the financial services provider’s stock, valued at approximately $710,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MET. Activest Wealth Management raised its stake in MetLife by 205.8% in the 4th quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 212 shares during the last quarter. Vermillion & White Wealth Management Group LLC raised its stake in shares of MetLife by 790.0% during the 3rd quarter. Vermillion & White Wealth Management Group LLC now owns 356 shares of the financial services provider’s stock valued at $29,000 after buying an additional 316 shares during the last quarter. Sound Income Strategies LLC raised its stake in shares of MetLife by 58.9% during the 4th quarter. Sound Income Strategies LLC now owns 383 shares of the financial services provider’s stock valued at $29,000 after buying an additional 142 shares during the last quarter. Foster Dykema Cabot & Partners LLC purchased a new position in shares of MetLife during the 3rd quarter valued at about $32,000. Finally, Albion Financial Group UT purchased a new position in shares of MetLife during the 4th quarter valued at about $32,000. Hedge funds and other institutional investors own 94.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on MET shares. UBS Group lifted their price objective on MetLife from $98.00 to $102.00 and gave the company a “buy” rating in a research note on Thursday, April 9th. Wells Fargo & Company lifted their price objective on MetLife from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Tuesday, May 12th. Keefe, Bruyette & Woods lifted their price objective on MetLife from $87.00 to $98.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Piper Sandler lifted their price objective on MetLife from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, Barclays lifted their price objective on MetLife from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $95.31.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife announced an expansion of its guaranteed retirement income lineup with a new flexible annuity option, which could support sales growth and reinforce its core insurance/retirement franchise. MetLife Expands Guaranteed Retirement Income Offering with Innovative Flexible Annuity Option
• Positive Sentiment: MetLife also added liquidity to an annuity product, another sign it is trying to make its retirement offerings more attractive to customers seeking flexibility and access to funds. MetLife Adds Liquidity To Annuity As Stock Trades Below Estimates
• Positive Sentiment: DOWLING & PARTN issued earnings estimates for MetLife above or near the Street for the next several years, including FY2027 EPS of $10.75 and FY2028 EPS of $12.00, reinforcing confidence in long-term profit growth.
• Neutral Sentiment: Several headlines mentioning “MetLife” were unrelated to the insurer and referred to MetLife Stadium or World Cup coverage, so they are unlikely to materially affect the stock.
• Negative Sentiment: A report that MetLife is clashing with Ares over a struggling football investment could raise some concern about a specific investment exposure, but it appears secondary to the more important product and earnings news. MetLife clashes with Ares over struggling football investment

MetLife Trading Up 1.1%

MET stock opened at $82.83 on Friday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $85.29. The stock has a market cap of $53.29 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 0.62 and a beta of 0.78. The business’s 50-day moving average is $76.49 and its 200 day moving average is $76.85.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.15. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The company had revenue of $14.18 billion for the quarter, compared to analysts’ expectations of $19.49 billion. During the same period in the previous year, the firm posted $1.96 EPS. MetLife’s revenue was up 2.7% compared to the same quarter last year. On average, sell-side analysts anticipate that MetLife, Inc. will post 9.96 EPS for the current fiscal year.

MetLife Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 9th. Investors of record on Tuesday, May 12th will be issued a $0.5925 dividend. This represents a $2.37 annualized dividend and a yield of 2.9%. The ex-dividend date is Tuesday, May 12th. This is a positive change from MetLife’s previous quarterly dividend of $0.57. MetLife’s payout ratio is presently 45.93%.

MetLife Company Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.